Lyft Executive Says Expects $82M Sequential Cost Of Revenue Headwind In Q4, Due To Insurance Renewal
-Reuters Citing Conference Call
AmerisourceBergen Announces Secondary Public Offering Of 10M Common Shares, Common Share Repurchase Of $500M
AmerisourceBergen Corporation (NYSE: ABC) (the "Company") announced today a secondary public offering of 10 millionsharesof common stock of the Company held by Walgreens Boots Alliance Holdings LLC (theAmerisourceBergen Corporation (NYSE:ABC) (the &
Ashland Global Holdings Q4 Adj. EPS $1.46 Beats $1.41 Estimate, Sales $631.00M Beat $627.74M Estimate
Ashland Global Holdings (NYSE:ASH) reported quarterly earnings of $1.46 per share which beat the analyst consensus estimate of $1.41 by 3.55 percent. This is a 19.67 percent increase over earnings of $1.22 per share from
Assured Guaranty Q3 Adj. EPS $2.11 Beats $0.84 Estimate, Sales $89.00M Miss $92.15M Estimate
Assured Guaranty (NYSE:AGO) reported quarterly earnings of $2.11 per share which beat the analyst consensus estimate of $0.84 by 151.19 percent. This is a 368.89 percent increase over earnings of $0.45 per share from the
Mosaic Q3 Adj. EPS $3.22 Misses $3.42 Estimate, Sales $5.35B Miss $5.76B Estimate
Mosaic (NYSE:MOS) reported quarterly earnings of $3.22 per share which missed the analyst consensus estimate of $3.42 by 5.85 percent. This is a 138.52 percent increase over earnings of $1.35 per share from the same
FS KKR Capital Q3 Adj. EPS $0.73 Beats $0.72 Estimate, Sales $411.00M Beat $402.21M Estimate
FS KKR Capital (NYSE:FSK) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.72 by 1.39 percent. This is a 14.06 percent increase over earnings of $0.64 per share from the same
Q2 Holdings Sees Q4 Revenue $148.4M-$150.4M Vs $157.64M Est., Adj. EBITDA $10.5M-$12.5M; See FY22 Revenue $568M-$570M Vs $579.34M Est., Adj. EBITDA $39M-$41M
Q2 Holdings is providing guidance for its fourth quarter of 2022 as follows:
Total non-GAAP revenue of $148.4 million to $150.4 million, which would represent year-over-year
Oportun Financial Sees Q4 Revenue $255M-$260M Vs $253.51M Est., Adj. EPS $0.24-$0.30; Sees FY22 Revenue $946M-$951M Vs $938.61M Est., Adj. EPS $2.19-$2.25
Financial Outlook for Fourth Quarter and Full Year 2022
Oportun is providing the following guidance for 4Q 2022 and full year 2022 as follows:
4Q 2022
Full Year
Ocular Therapeutix Q3 EPS $(0.31) Misses $(0.24) Estimate, Sales $11.91M Miss $14.27M Estimate
Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.24) by 29.17 percent. This is a 34.78 percent decrease over losses of $(0.23) per share
ShockWave Medical Q3 EPS $0.92 Beats $0.67 Estimate, Sales $131.33M Beat $123.97M Estimate
ShockWave Medical (NASDAQ:SWAV) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.67 by 37.31 percent. This is a 1740 percent increase over earnings of $0.05 per share from